- Do you have an idea for the development of a new pharmaceutical, diagnostic assay or biomedical device?
- Do you want to know if there is space for development of your intellectual property in the marketplace or is the area saturated with companies and patents that will frustrate your research and ultimately block development of your idea?
- Do you want to know the size of the potential market for your idea?
- Do you want to know what forms of financial support might be available for development of your idea?
- Do you want to know if there are companies committed to this area of research which could potentially partner with you in development?
These are some of the questions that can be answered fall by the Business and Medicine (BaM) Program. This program that debuted in 2017, pairs CMI researchers with teams of students in the Master of Microbial Biotechnology (MMB) Program. MMB students receive dual training in the science and business of biotechnology and are comfortable evaluating market potential, intellectual property, and the competitive landscape for biotechnology products and companies. BaM partnerships begin when, during the summer, CMI researchers submit a one paragraph description of their ideas and types of questions that they would like to pursue. The appropriate student teams are established and then in the fall, the MMB students spend five weeks focused on the problem. A detailed final report is delivered to each Principal Investigator (PI) and the groups present highlights in a combined meeting of all the researchers and student teams.
2017 BaM projects, PIs, and MMB Student Teams
- Development of businesses for gene edited swine, Jorge Piedrahita PI, Katie Sandlin*, Hannah Webb, Sterling Riggs, Megan Mackowiak, Jacob Hyman, and Andrew Harmon.
- Natural compounds against flaviviruses, Frank Scholle and Scott Laster PIs, Zach Jernigan*, Ryan Overcash, Swetha Srinivasan, Esteban Niaves, Carly Elkins, and Chris Carlin.
- Alkylamides for treatment of allergy, Scott Laster PI, Melody Paye*, David, Majeski, Caty Metcalf, Briggs Hagler, Sarah Grigg, and Ryan Larsen.
- Development of a gluten assay with clinical application A, Robert Voyksner PI, Hannah Seddon*, Mackenzie Nelson, Jake Trimble, and Mark Buckles.
- Development of a gluten assay with clinical application B, Robert Voyksner PI, Vincent Green*, Brook Peery, James Rebenski, Rivers Baker, Anne Claire DenHartog, and Abi Nails.
Each participating PI in 2017 was extremely pleased with the results and was highly complementary regarding the impact and value of the BaM Program to their research objectives. The wealth of knowledge gather from this program vast. PIs gained information about regulatory environments in different countries and how to plan effectively for product release. Some learned about disease applications for their products and the costs associated with starting a new business. Other PIs learned about companies already working in their area, and actually gained potential partners for their research projects. The participating researchers found BaM reports particularly helpful for grant submissions to the Chancellors Innovation Fund and the North Carolina Biotechnology Center.
Many thanks to Paul Hamilton, MMB Program Director, for making this happen!
To take advantage of this amazing resource beginning in July 2018 submit a 1 paragraph proposal describing your idea or invention and the type information you hope to gain from this consultation opportunity to Scott Laster, one of the Associate Directors of TPP. The staff of the MMB program will then respond and put your team into action.
Send proposals to email@example.com